The size of the Advanced Wound Care Market in North America market was valued at USD 5.34 Million in 2023 and is projected to reach USD 6.79 Million by 2032, with an expected CAGR of 3.50% during the forecast period. The North America advanced wound care market is concerned with the care of complicated, chronic, and non-healing wounds – such as diabetic ulcers, pressure ulcers, and post-surgical complications. It includes topical solutions, sophisticated dressings, wound management devices, and accident biologics that cut the time to healing and minimize infections’ probability in the wound. Main uses are in hospitals, repute care centres, and home care services. Major factors affecting the market include a growing incidence of diseases, change in the population’s demography, and a rise in the number of surgical operations. Contemporary trends focus on products such as the bioengineered skin substitutes, growth factors, and antimicrobial dressing. Similarly, increasing innovations in the wound healing devices including negative pressure wound therapy (NPWT) are also driving the market. Recent developments include: In October 2022, Wounds Canada and the Registered Nurses Association of Ontario (RNAO) planned to launch the Wound Care Champion Program (WCCP), designed to deliver evidence-informed, interdisciplinary, proficient-level wound education for front-line clinicians. The program will train regulated health professionals in Ontario, with 200 spots to be funded by the provincial Ministry of Health., In September 2022, Arch Therapeutics, Inc., a developer of novel self-assembling wound care and bio-surgical products, launched a multi-site clinical study to accelerate payor adoption and differentiate the benefits of the AC5 Advanced Wound System in treating challenging wounds. The Study launch completes the near-term commitments listed in the Company's recently announced reimbursement initiative to accelerate sales opportunities for AC5 in doctor's offices and wound care clinics.. Key drivers for this market are: Increase in the Geriatric Population, Rising Incidences of Chronic Wound. Potential restraints include: High-cost and Risk associated with Advanced Products. Notable trends are: Suture Sub-segment by Wound Closure Segment is Expected to Grow Over the Forecast Period.

Snapshot img

Wound Care Market Size 2024-2028

The wound care market size is valued to increase USD 6.95 billion, at a CAGR of 5.8% from 2023 to 2028. Increasing prevalence of acute and chronic wounds will drive the wound care market.

Major Market Trends & Insights

North America dominated the market and accounted for a 38% growth during the forecast period.
By Product - Advanced wound dressings segment was valued at USD 7.21 billion in 2022
By Application - Chronic wound segment accounted for the largest market revenue share in 2022

Market Size & Forecast

Market Opportunities: USD 57.53 million
Market Future Opportunities: USD 6952.40 million
CAGR : 5.8%
North America: Largest market in 2022

Market Summary

The market encompasses a continually evolving landscape shaped by advancements in core technologies and applications, service types, and product categories. With the increasing prevalence of acute and chronic wounds, the demand for combination wound dressings is on the rise. These dressings offer benefits such as improved patient comfort and faster healing times. However, the high cost of wound treatments and advanced wound care products poses a significant challenge for market growth. Regions like Europe and North America are witnessing substantial market activity, with Europe accounting for over 40% of the global market share due to its aging population and increasing healthcare expenditures. This dynamic market is further influenced by regulatory bodies such as the FDA and EMA, which ensure stringent safety and efficacy standards for wound care products.

What will be the Size of the Wound Care Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Wound Care Market Segmented and what are the key trends of market segmentation?

The wound care industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductAdvanced wound dressingsSurgical wound careTraditional wound careApplicationChronic woundAcute woundEnd UserHospitalsSpecialty ClinicsHome Care SettingsHospitalsSpecialty ClinicsHome Care SettingsDistribution ChannelInstitutional SalesRetail SalesInstitutional SalesRetail SalesGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalyUKMiddle East and AfricaEgyptKSAOmanUAEAPACChinaIndiaJapanSouth AmericaArgentinaBrazilRest of World (ROW)

By Product Insights

The advanced wound dressings segment is estimated to witness significant growth during the forecast period.

Advanced wound care solutions have gained significant traction in the healthcare industry due to the increasing prevalence of chronic wounds and burns. Among various advanced wound care products, advanced wound dressings have emerged as a leading segment, accounting for a substantial market share. These dressings encompass moist wound dressings and antimicrobial wound dressings. The advanced wound dressings segment's revenue growth can be attributed to several factors. The rising number of surgical procedures, increasing awareness about the clinical benefits of advanced wound dressings, and the growing aging population are primary drivers. Moreover, the adoption of advanced wound dressings in hospitals and wound care clinics and new product launches have further fueled market expansion. Despite these growth opportunities, the advanced wound dressings segment faces challenges. Intense competition among companies, high product costs, and the limited scope for differentiation leading to price wars adversely impact the market. The chronic wound management market is projected to expand at a brisk pace. According to estimates, the chronic wound management segment is expected to grow by 18.3% by 2025. Similarly, the tissue regeneration technologies segment is anticipated to grow by 15.5% during the same period. Pressure ulcer prevention, arterial ulcer treatment, and infection control protocols are crucial aspects of wound care. Topical antimicrobial agents, hydrogel wound dressings, and silver dressings antimicrobial play a vital role in infection control. Debridement techniques' efficacy and pain management strategies are also essential considerations in advanced wound care. Bioengineered skin substitutes, reconstructive surgery techniques, and collagen matrix dressings are other advanced wound care solutions gaining popularity. Hyperbaric oxygen therapy, ulcerative colitis treatment, and wound healing assessment are additional applications of advanced wound care solutions. In conclusion, the market is a dynamic and evolving landscape. Market trends include the growing adoption of advanced wound care solutions, increasing awareness about wound care, and the development of new technologies. Despite challenges, the mar

In North America Advanced Wound Care Market, offering valuable insights, key market trends, competitive landscape, and future outlook to support strategic decision.

Snapshot img

Chronic Wound Care Market Size 2024-2028

The chronic wound care market size is forecast to increase by USD 5.44 billion at a CAGR of 6.52% between 2023 and 2028.

Chronic wounds, including surgical wounds and trauma wounds, pose a significant challenge to healthcare systems due to their prevalence and high treatment costs. Factors such as wound infections, compromised immune function, and poor circulation contribute to the complexity of managing these wounds. In response, the market for chronic wound care solutions is witnessing notable trends, including the increasing adoption of advanced wound care technologies like moist wound dressings. Hospitals and specialty clinics are integrating wound care teams to improve patient outcomes and reduce healthcare costs. However, the high expense of chronic wound treatment remains a significant challenge for both providers and patients.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market represents a significant and growing segment within the healthcare industry. Chronic wounds, such as those resulting from diabetes, pressure ulcers, venous ulcers, arterial ulcers, and other chronic diseases including cancer and autoimmune diseases, present unique challenges for effective treatment and healing. Chronic diseases, including diabetes, are a leading cause of chronic wounds. Diabetes-related foot ulcers alone account for a substantial portion of chronic wounds, with an estimated 15% of people with diabetes developing a foot ulcer at some point in their lives.



Another significant contributor to chronic wounds is the changing lifestyle trends, leading to an increase in obesity, sedentary lifestyles, and unhealthy diets. These factors can result in a higher incidence of chronic wounds, particularly pressure ulcers, which affect individuals with limited mobility and those requiring extended hospital stays. The rising prevalence of chronic wounds is driving demand for advanced wound care solutions. Medical devices, such as medical tapes, bandages, and wound dressings, play a crucial role in the treatment and management of chronic wounds. These products are designed to promote wound healing, protect against infection, and provide a comfortable and secure covering for the wound.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Advanced dressing
  Traditional wound care
  Surgical wound care
  Wound therapy devices


Application

  Diabetic foot ulcers
  Pressure ulcers
  Venous leg ulcers


Geography

  North America

    US


  Europe

    Germany
    UK
    France


  Asia

    Japan


  Rest of World (ROW)

By Product Insights

The advanced dressing segment is estimated to witness significant growth during the forecast period.

In the realm of chronic wound care, various supplies play a pivotal role in ensuring optimal healing. Among these, sterilization supplies and hand sanitizers are essential for maintaining a clean and hygienic environment. Obesity is a significant contributor to chronic wounds, particularly in the form of lower extremity amputations. Advanced wound dressings, such as hydrocolloid, gel, film, alginate, and foam dressings, are utilized to protect the surrounding tissue and wound base. These dressings absorb exudate or hold onto moisture, enabling the wound to heal effectively. Advanced wound dressings, like alginate, offer high absorbency and transform into a gel upon contact with the wound surface.

Furthermore, this gel can be effortlessly removed with a dressing or washed off with sterile saline. Traditional wound dressings and surgical wound dressings also hold importance in wound care. Wound therapy devices, such as negative pressure wound therapy and electrical stimulation, further enhance the healing process. The market for chronic wound care supplies is segmented into the hospital segment and home healthcare segment. The hospital segment accounts for a larger share due to the availability of advanced medical facilities and specialized care. The home healthcare segment is expected to witness significant growth due to the increasing trend of home-based healthcare and the convenience it offers to patients.

Get a glance at the market report of share of various segments Request Free Sample

The advanced dressing segment was valued at USD 4.41 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 44% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during th

The North America Wound Closure and Advanced Wound Care report provides a detailed analysis of emerging investment pockets, highlighting current and future market trends. It offers strategic insights into capital flows and market shifts, guiding investors toward growth opportunities in key industry segments and regions.

The North America Advanced Wound Care report provides a detailed analysis of emerging investment pockets, highlighting current and future market trends. It offers strategic insights into capital flows and market shifts, guiding investors toward growth opportunities in key industry segments and regions.

The North America Advanced Wound Care Market size was valued at USD 5.1 billion in 2023 and is projected to reach USD 7.03 billion by 2032, exhibiting a CAGR of 4.7 % during the forecasts period. Recent developments include: In January 2023, Convatec launched the ConvaFoam in the U.S., which is a family of advanced foam dressings designed to meet the demands of medical professionals and their patients. This helped the company strengthen its presence in the U.S. market. , In July 2023, Coloplast announced the acquisition of Kerecis. This acquisition would help Coloplast expand its wound care offerings. , In January 2022, Coloplast announced the acquisition of Triad Life Sciences. This acquisition enhanced Convatec's position in advanced wound care in the U.S. and granted it access to a unique and complementary technological platform that improves patient outcomes and helps provide advanced wound treatment. .

The North American advanced wound care market is booming, projected to reach $7 billion by 2033. Discover key drivers, market trends, leading companies, and regional insights in this comprehensive analysis of wound dressings, bandages, and closure devices for chronic & acute wounds. Recent developments include: In October 2022, Wounds Canada and the Registered Nurses Association of Ontario (RNAO) planned to launch the Wound Care Champion Program (WCCP), designed to deliver evidence-informed, interdisciplinary, proficient-level wound education for front-line clinicians. The program will train regulated health professionals in Ontario, with 200 spots to be funded by the provincial Ministry of Health., In September 2022, Arch Therapeutics, Inc., a developer of novel self-assembling wound care and bio-surgical products, launched a multi-site clinical study to accelerate payor adoption and differentiate the benefits of the AC5 Advanced Wound System in treating challenging wounds. The Study launch completes the near-term commitments listed in the Company's recently announced reimbursement initiative to accelerate sales opportunities for AC5 in doctor's offices and wound care clinics.. Key drivers for this market are: Increase in the Geriatric Population, Rising Incidences of Chronic Wound. Potential restraints include: Increase in the Geriatric Population, Rising Incidences of Chronic Wound. Notable trends are: Suture Sub-segment by Wound Closure Segment is Expected to Grow Over the Forecast Period.

The market offers a diverse range of dressings, categorized by their material and properties: foam, silicone, hydrocolloid, and hydrogel dressings each cater to specific wound types and healing stages. Beyond dressings, the market encompasses a variety of devices and accessories that significantly impact wound management. Negative pressure wound therapy (NPWT) systems accelerate healing, while advanced debridement devices efficiently remove necrotic tissue. Furthermore, sophisticated wound assessment tools enable precise monitoring and optimized treatment strategies, contributing to improved patient outcomes and reduced healthcare costs. Recent developments include: July 2023: With an upfront cash payment of USD 1.2 billion, Coloplast has agreed to pay up to USD 1.3 billion for the acquisition of Kerecis, a creative and quickly expanding firm in the biologics wound care space. Entering the high-growth, US-centric biologics sector through Kerecis offers Coloplast a strategic opportunity to strengthen its position in the advanced wound care market., January 2022: Convatec Group acquired Triad Life Sciences Inc. to get entry into the lucrative wound biologics market. Convatec's Advanced Wound Care division in the US is anticipated to benefit from this, as their highly complementary product portfolios and business acumen will improve the company.. Notable trends are: Rising prevalence of acute and chronic wounds will boost the market growth.

The North America Wound Care market report offers a thorough competitive analysis, mapping key players’ strategies, market share, and business models. It provides insights into competitor dynamics, helping companies align their strategies with the current market landscape and future trends.

In North America Animal Wound Care Market, offering valuable insights, key market trends, competitive landscape, and future outlook to support strategic decision.

The Active Wound Care Market Report is Segmented by Product (Biomaterials, Skin Substitutes, Growth Factors), End User (Hospitals, Specialty Wound Clinics, Home Healthcare, Others), Application (Chronic Wounds, Acute Wounds), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

North America Advanced Wound Care Management Market was valued at USD 4.86 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 8.17% through 2029.

North America Wound Care Market size is predicted to be USD 14.4 Billion by 2035, with a 4.0% CAGR during the forecast period

USD 831.77 Million in 2024; projected USD 1891.78 Million by 2033; CAGR 9.56%.

USD 6484.46 Million in 2024; projected USD 9294.68 Million by 2033; CAGR 4.15%.

North America Wound Care Management Market size was valued at USD 5.16 Billion in 2024 and is projected to reach USD 6.79 Billion by 2032, growing at a CAGR of 3.5% from 2025-2032.

North America Wound Care Management Market: Definition/Overview

Wound care management refers to the comprehensive approach to treating and healing wounds, encompassing various stages from assessment to recovery. It involves understanding the etiology and pathophysiology of wounds, which can be acute or chronic, and implementing appropriate treatment strategies to promote healing. Key components of wound care management include cleaning and disinfecting the wound, debridement of necrotic tissue, infection control, and selecting suitable dressings to create an optimal healing environment. This process is crucial in preventing complications such as infections and ensuring effective recovery, particularly in patients with underlying health conditions that may impair healing.

The Advanced Wound Care Management Market Report is Segmented by Product (Wound Dressings, Acute Wound Care, and More), by Wound Type (Chronic Wounds and Acute Wounds), by End User (Hospitals, Home Healthcare, and More), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Sizes and Forecasts are Provided in Terms of Value (USD).

According to Cognitive Market Research, the global Active Wound Care market size will be USD 2,561.4 million in 2025. It will expand at a compound annual growth rate (CAGR) of 8.20% from 2025 to 2033.

North America held the major market share for more than 37% of the global revenue with a market size of USD 947.72 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.0% from 2025 to 2033.
Europe accounted for a market share of over 29% of the global revenue with a market size of USD 742.81 million.
APAC held a market share of around 24% of the global revenue with a market size of USD 614.74 million in 2025 and will grow at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2033.
South America has a market share of more than 3.8% of the global revenue with a market size of USD 97.33 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2033.
Middle East had a market share of around 4% of the global revenue and was estimated at a market size of USD 102.46 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2033.
Africa had a market share of around 2.2% of the global revenue and was estimated at a market size of USD 56.35 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2033.
Clinics is the fastest growing segment of the Active Wound Care industry

Market Dynamics of Active Wound Care Market

Key Drivers for Active Wound Care Market

Technological advancements in wound care products Is Expected To Boost Market Growth

Technological advancements in wound care products have significantly transformed the way acute and chronic wounds are managed, leading to faster healing, reduced infection rates, and improved patient outcomes. One of the most impactful developments has been the emergence of bioengineered skin substitutes and tissue-engineered products, which mimic natural skin and aid in the regeneration of damaged tissue. These include products containing living cells, growth factors, and extracellular matrix components that interact directly with the wound microenvironment to accelerate healing. In April 2024, Mölnlycke AB agreed to acquire the Austrian manufacturer of Granudacyn wound cleansing and moisturizing solutions, P.G.F. Industry Solutions GmbH. This acquisition will help the company to strengthen its wound cleansing and moisturizing portfolio.

https://www.molnlycke.com/en-in/news/media-room/press-release-molnlycke-health-care-acquires-p.g.f.-industry-solutions-gmbh-the-manufacturer-of-granudacyn-a-range-of-solutions-for-wound-cleansing-and-moisturising”/

Increasing incidence of diabetes and obesity To Boost Market Growth

The rising global incidence of diabetes and obesity has emerged as a significant driver for the active wound care market. Both conditions are closely linked to the development of chronic wounds, particularly diabetic foot ulcers, venous leg ulcers, and pressure ulcers. Diabetes impairs blood circulation and reduces the body’s ability to heal wounds effectively, often resulting in non-healing or slowly healing wounds that can lead to severe infections or even amputations. WHO Europe in April?2025 urged integrative obesity management as part of universal health coverage; 2023 saw rollout of an “Acceleration Plan to Stop Obesity. Obesity further compounds the problem by increasing pressure on the skin, particularly in immobile patients, and disrupting normal blood flow. This can lead to pressure injuries and delayed healing. Moreover, obese individuals often suffer from comorbidities such as peripheral vascular disease, which further limits tissue oxygenation and nutrient delivery to wounds.

Restraint Factor for the Active Wound Care Market

High cost of advanced wound care treatments, Will Limit Market Growth

The high cost of advanced wound care treatments remains a significant barrier to widespread adoption, especially in low- and middle-income countries. Unlike traditional wound care products such as gauze and basic dressings, advanced therapies—including bioengineered skin substitutes, growth factors, and negative pressure wound therapy (NPWT)—involve sophisticated manufacturing processes, specialized materials, and extensive clinical validation. These factors contribute to higher production costs, which are often passed on to healthcare providers and patients. ...

The US wound care management devices market, a significant segment of the global healthcare industry, is experiencing steady growth fueled by an aging population, increasing prevalence of chronic diseases like diabetes and obesity leading to higher incidence of chronic wounds, and advancements in wound care technologies. The market is characterized by a diverse range of products, including wound dressings, wound closure devices (sutures, staples, adhesives), and topical agents. The chronic wound segment, encompassing diabetic foot ulcers, pressure ulcers, and venous ulcers, dominates market share due to the long-term care requirements and associated higher costs. Acute wound management, encompassing surgical wounds and burns, also contributes significantly, driven by the increasing number of surgical procedures and burn injuries. Key players like Medtronic, 3M, Smith & Nephew, and Johnson & Johnson hold substantial market share, leveraging their established distribution networks and strong brand recognition. Competition is intense, with companies focusing on innovation, particularly in advanced wound dressings (e.g., those incorporating growth factors or antimicrobial agents) and minimally invasive wound closure techniques. The market's growth is projected to remain stable, albeit with a moderate CAGR, reflecting the ongoing need for effective wound care solutions and ongoing technological advancements. However, factors such as high healthcare costs and reimbursement challenges present potential restraints to market expansion. Future growth will likely be driven by increased adoption of advanced wound care technologies, particularly in the home healthcare setting, and expanding access to specialized wound care services in underserved areas. The market is segmented geographically, with North America representing a significant portion of the overall market share due to factors such as high healthcare expenditure, advanced healthcare infrastructure, and strong presence of key market players. Growth in other regions like Asia Pacific is expected to be driven by rising healthcare awareness, increasing disposable incomes, and improving healthcare infrastructure. Europe also represents a substantial market, influenced by similar factors although at a potentially slower growth rate compared to the Asia Pacific region. Overall, the US wound care management devices market presents a robust and dynamic landscape, characterized by a blend of established players and emerging technologies, poised for continued growth driven by both demographic shifts and technological advancements in wound care. Recent developments include: April 2023: 3M Health Care's innovative 3M Veraflo Therapy, with both 3M Veraflo Cleanse Choice Complete Dressing and 3M™ V.A.C. Veraflo Cleanse Choice Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue and wound debris which reduces the number of surgical debridements required, while promoting granulation tissue formation, creating an environment that promotes wound healing., January 2023: Convatec launched the ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients in the United States. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, making it the simple dressing choice for wound management and skin protection.. Key drivers for this market are: Increasing Incidences of Chronic Wounds, Ulcers and Diabetic Ulcers, Increase in the Number of Surgical Procedures; Rising Aging Population. Potential restraints include: Increasing Incidences of Chronic Wounds, Ulcers and Diabetic Ulcers, Increase in the Number of Surgical Procedures; Rising Aging Population. Notable trends are: Sutures Segment is Expected to Grow Significantly Over the Forecast Period.